12 Hrs
Source:
اليوم السابع
_1777352142843_145525226.png&w=64&q=75){kind=small}
Source: اليوم السابع
12 Hrsاليوم السابع
Source: اليوم السابع
12 HrsReady to play
Ready to play
Researchers at City of Hope developed an experimental treatment called SER-155 to prevent bloodstream infections in cancer patients undergoing stem cell transplants from donors. It contains 16 selected types of beneficial bacteria. In phase 1 clinical trials, the treatment was well tolerated, and the bacteria became established in patients’ microbiomes. Levels of harmful pathogens fell, along with the incidence of infections and the risks associated with them. The findings are preliminary: the study did not focus on clinical outcomes, and larger trials are still needed before the treatment can become available.
Notice: This Is an AI-Generated Summary
Comments (0)